Preparation method of rich-batinib
A three-step synthesis method using low-cost (S)-3-hydroxypyrrolidine for futibatinib production addresses inefficiencies in existing methods by eliminating chromatographic separation and protective groups, resulting in high yield and simplified purification suitable for industrial use.
Patent Information
- Application Number
- CN202411200515.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-29
- Publication Date
- 2024-12-06
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The existing preparation method for futibatinib is inefficient and costly, requiring chiral chromatographic column separation and multiple protective group steps, which prolongs reaction times and lowers overall yield.
A three-step synthesis method using low-cost single-configuration (S)-3-hydroxypyrrolidine as a starting material, involving intramolecular cyclization and substitution reactions without protective groups, to produce futibatinib efficiently.
The method achieves high yield, simplifies purification, reduces operational complexity, and is environmentally friendly, making it suitable for large-scale industrial production.
Smart Images

Figure BDA0005017725760000012 
Figure BDA0005017725760000021 
Figure BDA0005017725760000061
Abstract
Description
Technical Field
[0001] The present invention relates to the field of biomedicine technology, and in particular to a method for preparing fulvibatinib. Background Art
[0002] Futibatinib (trade name: ) is an oral, covalently bound, irreversible fibroblast growth factor receptor (FGFR) 1-4 inhibitor developed by Taiho Oncology and Taiho Pharmaceutical for the treatment of cancers, including cholangiocarcinoma, breast cancer, gastric cancer, urothelial carcinoma, esophageal cancer, and non-small cell lung cancer. Futebatinib was approved by the U.S. FDA on September 30, 2022 for the treatment of adult patients with previously treated, unresectable, locally advanced or metastatic intrahepatic cholangiocarcinoma with FGFR2 gene fusion or other rearrangements. The chemical structure of Futebatinib is shown in Formula I:
[0003]
[0004] However, the current preparation method for fulvebatinib still needs to be improved. Summary of the invention
[0005] The present invention aims to solve one of the technical problems in the related art at least to a certain extent. To this end, one object of the present invention is to propose a method for preparing a compound shown in formula I, fulvebatinib. Compared with the prior art, the raw materials of the preparation method of the present invention undergo intramolecular cyclization; the invention uses a low-cost single-configuration (S)-3-hydroxypyrrolidine (compound shown in formula 1) as a starting material, wherein the imino group is first docked with the acryloyl group, and the hydroxyl group is then docked with the methanesulfonyl group, and the resulting product is then subjected to a substitution reaction with the compound shown in formula 4 to obtain the product compound shown in formula I, fulvebatinib.
[0006] In one aspect of the present invention, the present invention provides a method for preparing the compound fulbatinib represented by formula I. According to an embodiment of the present invention, the preparation method comprises:
[0007] (1) contacting the compound represented by Formula 1 with an organic base A and acryloyl chloride to obtain the compound represented by Formula 2;
[0008] (2) contacting the compound represented by Formula 2 with a basic substance B and methanesulfonyl chloride to obtain the compound represented by Formula 3;
[0009] (3) contacting the compound represented by Formula 4, the compound represented by Formula 3, and an organic base C to obtain the compound represented by Formula I, fultebatinib,
[0010]
[0011] The inventors found that, using the preparation method of the present invention, the compound represented by Formula 1, triethylamine and acryloyl chloride are used as starting materials, and a total of three steps of reaction are performed to successfully synthesize and prepare the target product, fulvibatinib.
[0012] The term "contact" as used herein should be understood in a broad sense, and can be any manner that allows at least two reactants to undergo a chemical reaction, such as mixing the two reactants under appropriate conditions. If necessary, the reactants to be contacted can be mixed under stirring, and thus, the type of stirring is not particularly limited, and can be mechanical stirring, i.e. stirring under the action of mechanical force.
[0013] In this document, the terms "first" and "second" are used for descriptive purposes only and should not be understood as indicating or implying relative importance or implicitly indicating the number of the indicated technical features. Thus, a feature defined as "first" or "second" may explicitly or implicitly include one or more of the features. In the description of the present invention, the meaning of "plurality" is two or more, unless otherwise clearly and specifically defined.
[0014] According to an embodiment of the present invention, the method for preparing the compound represented by Formula 2, the compound represented by Formula 3, and the compound represented by Formula I may also have at least one of the following additional technical features:
[0015] According to an embodiment of the present invention, the chemical reaction described in the present invention can be carried out according to any method known in the art. The source of the raw materials of the compound shown in Formula 2, the compound shown in Formula 3, and the compound shown in Formula 1 is not particularly limited, and it can be prepared by any known method or commercially available. For example, the CAS of the compound shown in Formula 1 is: 100243-39-8, and the CAS of the compound shown in Formula 4 is: 1448170-49-7.
[0016] According to an embodiment of the present invention, in step (1), the contacting method of the compound represented by Formula 1 with the organic base A and acryloyl chloride is not particularly limited. Thus, the efficiency of the contact reaction between the compound represented by Formula 1 and the organic base A and acryloyl chloride can be improved, the reaction speed can be accelerated, and the efficiency of preparing the compound represented by Formula 2 by using this method can be further improved.
[0017] According to an embodiment of the present invention, in step (1), the following steps are included: at room temperature, the compound shown in formula 1 and the organic base A are added to a reaction bottle, dry dichloromethane is added, and the mixture is stirred evenly, the reaction solution is cooled to -15°C to -5°C, and acryloyl chloride is slowly added dropwise, and after the addition is completed, the mixture is stirred at -15°C to -5°C for 2 hours and 45 minutes to 3.5 hours, and TLC shows that the raw materials are completely reacted, a saturated ammonium chloride solution is added to the reaction solution to quench the reaction, dichloromethane is added to extract, the organic phases are combined, saturated brine is added for washing, the mixture is dried over anhydrous sodium sulfate, and the filtrate is concentrated under reduced pressure to evaporate the solvent to obtain the compound shown in formula 2. Thus, the efficiency of the contact reaction between the compound shown in formula 1 and the organic base A and acryloyl chloride can be improved, the reaction speed can be accelerated, and the efficiency of preparing the compound shown in formula 2 by using this method can be further improved.
[0018] According to an embodiment of the present invention, in step (1), the molar ratio of the compound represented by Formula 1 to the organic base A and acryloyl chloride is 1:(1.2-1.5):(1.0-1.2), and preferably the molar ratio of the compound represented by Formula 1 to the organic base A and acryloyl chloride is 1:1.3:1.05. Thus, the efficiency of preparing the compound represented by Formula 2 by this method can be further improved.
[0019] According to an embodiment of the present invention, in step (1), the organic base A is at least one selected from triethylamine, isopropylamine, ethylenediamine, and DIPEA, and preferably the organic base A is selected from triethylamine.
[0020] According to an embodiment of the present invention, in step (1), after the dropwise addition is completed, the reaction is preferably maintained at -12°C to -8°C with stirring for 3 hours.
[0021] According to a specific embodiment of the present invention, in step (1), the following steps are included: at room temperature, the compound represented by formula 1 (8.71 g, 0.1 mol) and triethylamine (13.16 g, 0.13 mol) are added to a reaction bottle, dry dichloromethane (120 mL) is added, and the mixture is stirred evenly. The reaction solution is cooled to -12°C to -8°C and acryloyl chloride (9.50 g, 0.105 mol) is slowly added dropwise. After the addition is completed, the mixture is stirred at -12°C to -8°C for 3 hours. TLC shows that the raw materials have reacted completely. Saturated ammonium chloride solution (25 mL) is added to the reaction solution to quench the reaction. Dichloromethane (2×25 mL) is added to extract. After the organic phases are combined, 25 mL of saturated brine is added for washing, and the mixture is dried over anhydrous sodium sulfate. The filtrate is concentrated under reduced pressure to evaporate the solvent to obtain the compound represented by formula 2. The yield is 11.70 g and the yield is 82.9%.
[0022] According to an embodiment of the present invention, in step (2), the contacting method of the compound represented by Formula 2 with the alkaline substance B and methanesulfonyl chloride is not particularly limited. Thus, the efficiency of the contact reaction between the compound represented by Formula 2 and the alkaline substance B and methanesulfonyl chloride can be improved, the reaction speed can be accelerated, and the efficiency of preparing the compound represented by Formula 3 by using this method can be further improved.
[0023] According to an embodiment of the present invention, in step (2), the following steps are included: at room temperature, the compound shown in formula 2 and the alkaline substance B are placed in a reaction bottle, dichloromethane is added, the reaction solution is cooled to about 0°C, and methanesulfonyl chloride is slowly added dropwise, and the temperature is naturally raised to 20°C to 30°C after the addition is completed, and the reaction is stirred for 3 hours to 3.5 hours. After the reaction is completed, post-treatment is performed, a saturated ammonium chloride solution is added to the reaction solution to quench the reaction, dichloromethane is added to extract, the organic phases are combined and then washed with saturated brine, dried over anhydrous sodium sulfate, the filtrate is concentrated under reduced pressure to evaporate the solvent, and the concentrate is purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent to obtain the compound shown in formula 3. Thus, the efficiency of the contact reaction between the compound shown in formula 2 and the alkaline substance B and methanesulfonyl chloride can be improved, the reaction speed can be accelerated, and the efficiency of preparing the compound shown in formula 3 by using this method can be further improved.
[0024] According to an embodiment of the present invention, in step (2), the molar ratio of the compound shown in Formula 2 to the alkaline substance B and methanesulfonyl chloride is 1:(1.4-1.6):(1.1-1.3), and preferably the molar ratio of the compound shown in Formula 2 to the alkaline substance B and methanesulfonyl chloride is 1:1.5:1.2. Thus, the efficiency of preparing the compound shown in Formula 3 by this method can be further improved.
[0025] According to an embodiment of the present invention, in step (2), the alkaline substance B is selected from triethylamine, isopropylamine, ethylenediamine, DIPEA, K 2 CO 3 、Na 2 CO 3 At least one, preferably basic substance B is selected from triethylamine.
[0026] According to an embodiment of the present invention, in step (2), the volume ratio of petroleum ether to ethyl acetate in the petroleum ether / ethyl acetate mixed solvent is (8-12):1, and preferably the volume ratio of petroleum ether / ethyl acetate mixed solvent is 10:1.
[0027] According to an embodiment of the present invention, in step (2), preferably, after the dropwise addition is completed, the temperature is naturally raised to 23° C. to 27° C., and the reaction is stirred for 3 hours and 15 minutes.
[0028] According to a specific embodiment of the present invention, in step (2), the following steps are included: at room temperature, the compound of formula 2 (14.12 g, 0.1 mol) and triethylamine (15.18 g, 0.15 mol) are placed in a reaction bottle, dichloromethane (250 mL) is added, the reaction solution is cooled to about 0°C, and methanesulfonyl chloride (13.74 g, 0.12 mol) is slowly added dropwise, and the temperature is naturally raised to 23°C to 27°C after the addition is completed, and the reaction is stirred for 3 hours and 15 minutes. After the reaction is completed, post-treatment is performed, saturated ammonium chloride solution (50 mL) is added to the reaction solution to quench the reaction, and dichloromethane (2×50 mL) is added to extract, the organic phases are combined, washed with 50 ml of saturated brine, dried over anhydrous sodium sulfate, and the filtrate is concentrated under reduced pressure to evaporate the solvent. The concentrate is purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 10:1 to obtain a compound of formula 3, with an amount of 20.28 g and a total yield of 92.5%.
[0029] According to an embodiment of the present invention, in step (3), the contacting method of the compound represented by Formula 4, the compound represented by Formula 3, and the organic base C is not particularly limited. Thus, the efficiency of the contact reaction of the compound represented by Formula 4, the compound represented by Formula 3, and the organic base C can be improved, the reaction speed can be accelerated, and the efficiency of preparing the compound represented by Formula I by using this method can be further improved.
[0030] According to an embodiment of the present invention, in step (3), the following steps are included: at room temperature, the compound shown in formula 4, the compound shown in formula 3 and the inorganic base C are placed in a reaction bottle, DMF is added and dissolved, and the reaction is maintained at 45°C to 60°C for 2 to 3 hours. TLC shows that the raw materials are completely reacted, and the reaction solution is cooled to room temperature, and then post-processed, water is added for washing, ethyl acetate is extracted, and the organic phase is combined and then saturated brine is added for washing, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The concentrate is purified by silica gel column chromatography with a petroleum ether / ethyl acetate mixed solvent to obtain the compound shown in formula I, fulvebatinib. Thus, the efficiency of the contact reaction of the compound shown in formula 4, the compound shown in formula 3, and the organic base C can be improved, the reaction speed can be accelerated, and the efficiency of preparing the compound shown in formula I, fulvebatinib, by using this method can be further improved.
[0031] According to an embodiment of the present invention, in step (3), the molar ratio of the compound represented by Formula 4, the compound represented by Formula 3, and the organic base C is 1:(1.3-1.6):(1.1-1.4), and preferably the molar ratio of the compound represented by Formula 4, the compound represented by Formula 3, and the organic base C is 1:1.5:1.2. Thus, the efficiency of preparing the compound represented by Formula I by this method can be further improved.
[0032] According to an embodiment of the present invention, in step (3), the inorganic base C is at least one selected from sodium carbonate or potassium carbonate, and preferably the inorganic base C is selected from potassium carbonate.
[0033] According to an embodiment of the present invention, in step (3), the volume ratio of petroleum ether to ethyl acetate in the petroleum ether / ethyl acetate mixed solvent is (3-8):1, preferably the volume ratio of petroleum ether to ethyl acetate is 5:1.
[0034] According to an embodiment of the present invention, in step (3), the reaction is preferably stirred at 50° C. to 55° C. for 2.5 hours.
[0035] According to a specific embodiment of the present invention, in step (3), the following steps are included: at room temperature, the compound represented by formula 4 (29.53 g, 0.1 mol), the compound represented by formula 3 (32.89 g, 0.15 mol) and K 2 CO 3 (16.58 g, 0.12 mol) was placed in a reaction bottle, and DMF (250 mL) was added to dissolve it. The temperature was kept at 50°C to 55°C with stirring for 2.5 hours. TLC showed that the raw material was completely reacted. The reaction solution was cooled to room temperature and then post-treated. 150 mL of water was added for washing, and ethyl acetate (2×150 ml) was used for extraction. The organic phases were combined and washed with 200 mL of saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 5:1 to obtain the compound represented by formula I, fulvibatinib, with an yield of 20.55 g, a total yield of 49.1%, and a purity of 99.7%.
[0036] According to a specific embodiment of the present invention, the synthesis route of the compound fulbatinib represented by formula I can be as follows:
[0037]
[0038] Compared with the prior art, the preparation method of Futebatinib described in the present invention has at least the following beneficial effects:
[0039] 1. Compared with the prior art, the raw materials of the preparation method of the present invention undergo intramolecular cyclization; the present invention adopts low-cost single-configuration (S)-3-hydroxypyrrolidine (compound shown in Formula 1) as the starting raw material, wherein the imino group is first docked with the acryloyl group, and the hydroxyl group is then docked with the methanesulfonyl group, and the obtained product is then subjected to a substitution reaction with the compound shown in Formula 4 to obtain the product compound shown in Formula I, i.e., fulvebatinib.
[0040] 2. Compared with the prior art methods, the present invention has the following significant advantages: (1) The low-priced single-configuration (S)-3-hydroxypyrrolidine is used as the starting material, which avoids the chiral chromatographic column separation in the prior art methods. (2) In the prior art, when (S)-3-hydroxypyrrolidine is docked with an acryloyl group and a methylsulfonyl group twice, the -OH group is protected with a protective group before docking with the methylsulfonyl group. The present invention achieves the experimental purpose with a high yield by selecting a suitable temperature without the need for a protective group. At the same time, the post-processing operation steps are simplified, the operation time is saved, and it is suitable for scaled-up production. (3) The prior art method is to protect the imino group of (S)-3-hydroxypyrrolidine before participating in the reaction. The subsequent reaction also requires the removal of this protective group, resulting in a longer reaction step and a lower overall yield. The present invention first docks the imino group of (S)-3-hydroxypyrrolidine with the acryloyl group, shortening the reaction step. (4) The post-processing of the present invention is also more friendly to the environment and the health of operators; the post-processing is simple and easy to operate, and the total product yield is high.
[0041] 3. In summary, this route has the advantages of low raw material cost, high yield, simple purification, etc. It is easy to industrialize and is very suitable for large-scale industrial production. DETAILED DESCRIPTION
[0042] The embodiments of the present invention are described in detail below. The embodiments described below are exemplary and are only used to explain the present invention, and should not be construed as limiting the present invention. If no specific techniques or conditions are specified in the embodiments, the techniques or conditions described in the literature in this area or the product specifications are used. The reagents or instruments used that do not specify the manufacturer are all conventional products that can be obtained commercially.
[0043] Example 1 Synthesis of the compound represented by formula 2
[0044] At room temperature, the compound represented by formula 1 (8.71 g, 0.1 mol) and triethylamine (13.16 g, 0.13 mol) were added to a reaction flask, and dry dichloromethane (120 mL) was added and stirred evenly. The reaction solution was cooled to -12°C to -8°C and acryloyl chloride (9.50 g, 0.105 mol) was slowly added dropwise. After the addition was completed, the temperature was maintained at -12°C to -8°C and stirred for 3 hours. TLC showed that the raw materials were completely reacted. Saturated ammonium chloride solution (25 mL) was added to the reaction solution to quench the reaction. Dichloromethane (2×25 mL) was added to extract. After the organic phases were combined, 25 mL of saturated brine was added for washing, and the mixture was dried over anhydrous sodium sulfate. The filtrate was concentrated under reduced pressure to evaporate the solvent to obtain the compound represented by formula 2, with an amount of 11.70 g and a yield of 82.9%.
[0045] LC-MS (APCI): m / z = 141.1 (M+1) + .
[0046] Example 2 Synthesis of the compound represented by formula 2
[0047] At room temperature, the compound represented by formula 1 (8.71 g, 0.1 mol) and triethylamine (12.14 g, 0.12 mol) were added to a reaction flask, and dry dichloromethane (120 mL) was added and stirred evenly. The reaction solution was cooled to -8°C to -5°C and acryloyl chloride (9.05 g, 0.10 mol) was slowly added dropwise. After the addition was completed, the temperature was maintained at -8°C to -5°C and stirred for 2 hours and 45 minutes. TLC showed that the raw material was completely reacted. Saturated ammonium chloride solution (25 mL) was added to the reaction solution to quench the reaction. Dichloromethane (2×25 mL) was added to extract. After the organic phases were combined, 25 mL of saturated brine was added for washing, and the mixture was dried over anhydrous sodium sulfate. The filtrate was concentrated under reduced pressure to evaporate the solvent to obtain the compound represented by formula 2, with an amount of 11.35 g and a yield of 80.4%.
[0048] Example 3 Synthesis of the compound represented by formula 2
[0049] At room temperature, the compound represented by formula 1 (8.71 g, 0.1 mol) and triethylamine (15.18 g, 0.15 mol) were added to a reaction flask, and dry dichloromethane (120 mL) was added and stirred evenly. The reaction solution was cooled to -15°C to -10°C and acryloyl chloride (10.86 g, 0.12 mol) was slowly added dropwise. After the addition was completed, the temperature was maintained at -15°C to -10°C and stirred for 3.5 hours. TLC showed that the raw material was completely reacted. Saturated ammonium chloride solution (25 mL) was added to the reaction solution to quench the reaction. Dichloromethane (2×25 mL) was added to extract. After the organic phases were combined, 25 mL of saturated brine was added for washing, and the mixture was dried over anhydrous sodium sulfate. The filtrate was concentrated under reduced pressure to evaporate the solvent to obtain the compound represented by formula 2, with an amount of 11.62 g and a yield of 82.3%.
[0050] Example 4 Synthesis of the compound represented by formula 2
[0051] The experiment of replacing the triethylamine in Example 1 with isopropylamine:
[0052] At room temperature, the compound represented by formula 1 (8.71 g, 0.1 mol) and isopropylamine (7.68 g, 0.13 mol) were added to a reaction flask, and dry dichloromethane (120 mL) was added and stirred evenly. The reaction solution was cooled to -12°C to -8°C and acryloyl chloride (9.50 g, 0.105 mol) was slowly added dropwise. After the addition was completed, the temperature was maintained at -12°C to -8°C and stirred for 3 hours. TLC showed that the raw materials were completely reacted. Saturated ammonium chloride solution (25 mL) was added to the reaction solution to quench the reaction. Dichloromethane (2×25 mL) was added to extract. After the organic phases were combined, 25 mL of saturated brine was added for washing, and the mixture was dried over anhydrous sodium sulfate. The filtrate was concentrated under reduced pressure to evaporate the solvent to obtain the compound represented by formula 2, with an amount of 11.18 g and a yield of 79.2%.
[0053] Example 5 Synthesis of the compound represented by formula 2
[0054] The experiment of replacing the triethylamine in Example 1 with ethylenediamine:
[0055] At room temperature, the compound represented by formula 1 (8.71 g, 0.1 mol) and ethylenediamine (7.81 g, 0.13 mol) were added to a reaction flask, and dry dichloromethane (120 mL) was added and stirred evenly. The reaction solution was cooled to -12°C to -8°C and acryloyl chloride (9.50 g, 0.105 mol) was slowly added dropwise. After the addition was completed, the temperature was maintained at -12°C to -8°C and stirred for 3 hours. TLC showed that the raw materials were completely reacted. Saturated ammonium chloride solution (25 mL) was added to the reaction solution to quench the reaction. Dichloromethane (2×25 mL) was added to extract. After the organic phases were combined, 25 mL of saturated brine was added for washing, and the mixture was dried over anhydrous sodium sulfate. The filtrate was concentrated under reduced pressure to evaporate the solvent to obtain the compound represented by formula 2, with an amount of 11.11 g and a yield of 78.7%.
[0056] Example 6 Synthesis of the compound represented by formula 2
[0057] Experiment in which the triethylamine in Example 1 is replaced by DIPEA:
[0058] At room temperature, the compound represented by formula 1 (8.71 g, 0.1 mol) and DIPEA (16.80 g, 0.13 mol) were added to a reaction flask, and dry dichloromethane (120 mL) was added and stirred evenly. The reaction solution was cooled to -12°C to -8°C and acryloyl chloride (9.50 g, 0.105 mol) was slowly added dropwise. After the addition was completed, the temperature was maintained at -12°C to -8°C and stirred for 3 hours. TLC showed that the raw material was completely reacted. Saturated ammonium chloride solution (25 mL) was added to the reaction solution to quench the reaction. Dichloromethane (2×25 mL) was added to extract. After the organic phases were combined, 25 mL of saturated brine was added for washing, and the mixture was dried over anhydrous sodium sulfate. The filtrate was concentrated under reduced pressure to evaporate the solvent to obtain the compound represented by formula 2, with an amount of 11.29 g and a yield of 80.0%.
[0059] Comparative Example 1: Synthesis of the compound represented by Formula 2
[0060] The molar ratio of the compound represented by Formula 1, triethylamine and acryloyl chloride was adjusted to 1:1.6:1.5, and the stirring reaction time was extended to 5 hours.
[0061] At room temperature, the compound represented by formula 1 (8.71 g, 0.1 mol) and triethylamine (16.19 g, 0.16 mol) were added to a reaction flask, and dry dichloromethane (120 mL) was added and stirred evenly. The reaction solution was cooled to -12°C to -8°C and acryloyl chloride (13.58 g, 0.15 mol) was slowly added dropwise. After the addition was completed, the temperature was maintained at -12°C to -8°C and stirred for 5 hours. TLC showed that the raw materials were completely reacted. Saturated ammonium chloride solution (25 mL) was added to the reaction solution to quench the reaction. Dichloromethane (2×25 mL) was added to extract. After the organic phases were combined, 25 mL of saturated brine was added for washing, and the mixture was dried over anhydrous sodium sulfate. The filtrate was concentrated under reduced pressure to evaporate the solvent to obtain the compound represented by formula 2, with an amount of 10.55 g and a yield of 74.7%.
[0062] Example 7 Synthesis of the compound represented by formula 3
[0063] At room temperature, the compound of formula 2 (14.12 g, 0.1 mol) and triethylamine (15.18 g, 0.15 mol) were placed in a reaction bottle, and dichloromethane (250 mL) was added. The reaction solution was cooled to about 0°C and methanesulfonyl chloride (13.74 g, 0.12 mol) was slowly added dropwise. After the addition was completed, the temperature naturally rose to 23°C to 27°C, and the reaction was stirred for 3 hours and 15 minutes. After the reaction was completed, post-treatment was performed, saturated ammonium chloride solution (50 mL) was added to the reaction solution to quench the reaction, and dichloromethane (2×50 mL) was added to extract. After the organic phases were combined, 50 ml of saturated brine was added to wash, and the mixture was dried over anhydrous sodium sulfate. The filtrate was concentrated under reduced pressure to evaporate the solvent, and the concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 10:1 to obtain the compound of formula 3, with an amount of 20.28 g and a total yield of 92.5%.
[0064] LC-MS (APCI): m / z = 220.1 (M+1) + .
[0065] Example 8 Synthesis of the compound represented by formula 3
[0066] At room temperature, the compound of formula 2 (14.12 g, 0.1 mol) and triethylamine (14.17 g, 0.14 mol) were placed in a reaction bottle, and dichloromethane (250 mL) was added. The reaction solution was cooled to about 0°C and methanesulfonyl chloride (12.60 g, 0.11 mol) was slowly added dropwise. After the addition was completed, the temperature naturally rose to 27°C to 30°C, and the reaction was stirred for 3 hours. After the reaction was completed, post-treatment was performed, saturated ammonium chloride solution (50 mL) was added to the reaction solution to quench the reaction, and dichloromethane (2×50 mL) was added to extract. After the organic phases were combined, 50 ml of saturated brine was added for washing, and the mixture was dried over anhydrous sodium sulfate. The filtrate was concentrated under reduced pressure to evaporate the solvent, and the concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 8:1 to obtain the compound of formula 3, with an amount of 19.49 g and a total yield of 88.9%.
[0067] Example 9 Synthesis of the compound represented by formula 3
[0068] At room temperature, the compound of formula 2 (14.12 g, 0.1 mol) and triethylamine (16.19 g, 0.16 mol) were placed in a reaction bottle, and dichloromethane (250 mL) was added. The reaction solution was cooled to about 0°C and methanesulfonyl chloride (14.89 g, 0.13 mol) was slowly added dropwise. After the addition was completed, the temperature naturally rose to 20°C to 24°C, and the reaction was stirred for 3.5 hours. After the reaction was completed, post-treatment was performed, saturated ammonium chloride solution (50 mL) was added to the reaction solution to quench the reaction, and dichloromethane (2×50 mL) was added to extract. After the organic phases were combined, 50 ml of saturated brine was added to wash, and the mixture was dried over anhydrous sodium sulfate. The filtrate was concentrated under reduced pressure to evaporate the solvent, and the concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 12:1 to obtain the compound of formula 3, with an amount of 20.02 g and a total yield of 91.3%.
[0069] Example 10 Synthesis of the compound represented by formula 3
[0070] At room temperature, the compound of formula 2 (14.12 g, 0.1 mol) and isopropylamine (8.87 g, 0.15 mol) were placed in a reaction bottle, and dichloromethane (250 mL) was added. The reaction solution was cooled to about 0°C and methanesulfonyl chloride (13.74 g, 0.12 mol) was slowly added dropwise. After the addition was completed, the temperature naturally rose to 23°C to 27°C, and the reaction was stirred for 3 hours and 15 minutes. After the reaction was completed, post-treatment was performed, saturated ammonium chloride solution (50 mL) was added to the reaction solution to quench the reaction, and dichloromethane (2×50 mL) was added to extract. After the organic phases were combined, 50 ml of saturated brine was added to wash, and the mixture was dried over anhydrous sodium sulfate. The filtrate was concentrated under reduced pressure to evaporate the solvent, and the concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 10:1 to obtain the compound of formula 3, with an amount of 19.84 g and a total yield of 90.5%.
[0071] Example 11 Synthesis of the compound represented by formula 3
[0072] At room temperature, the compound of formula 2 (14.12 g, 0.1 mol) and ethylenediamine (9.02 g, 0.15 mol) were placed in a reaction bottle, and dichloromethane (250 mL) was added. The reaction solution was cooled to about 0°C and methanesulfonyl chloride (13.74 g, 0.12 mol) was slowly added dropwise. After the addition was completed, the temperature naturally rose to 23°C to 27°C, and the reaction was stirred for 3 hours and 15 minutes. After the reaction was completed, post-treatment was performed, saturated ammonium chloride solution (50 mL) was added to the reaction solution to quench the reaction, and dichloromethane (2×50 mL) was added to extract. After the organic phases were combined, 50 ml of saturated brine was added for washing, and the mixture was dried over anhydrous sodium sulfate. The filtrate was concentrated under reduced pressure to evaporate the solvent, and the concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 10:1 to obtain the compound of formula 3, with an amount of 19.38 g and a total yield of 88.4%.
[0073] Example 12 Synthesis of the compound represented by formula 3
[0074] At room temperature, the compound of formula 2 (14.12 g, 0.1 mol) and DIPEA (19.39 g, 0.15 mol) were placed in a reaction bottle, and dichloromethane (250 mL) was added. The reaction solution was cooled to about 0°C and methanesulfonyl chloride (13.74 g, 0.12 mol) was slowly added dropwise. After the addition was completed, the temperature naturally rose to 23°C to 27°C, and the reaction was stirred for 3 hours and 15 minutes. After the reaction was completed, post-treatment was performed, saturated ammonium chloride solution (50 mL) was added to the reaction solution to quench the reaction, and dichloromethane (2×50 mL) was added to extract. After the organic phases were combined, 50 ml of saturated brine was added to wash, and the mixture was dried over anhydrous sodium sulfate. The filtrate was concentrated under reduced pressure to evaporate the solvent, and the concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 10:1 to obtain the compound of formula 3, with an amount of 19.95 g and a total yield of 91.0%.
[0075] Example 13 Synthesis of the compound represented by formula 3
[0076] At room temperature, the compound shown in formula 2 (14.12 g, 0.1 mol), Na 2 CO 3(15.90g, 0.15mol) was placed in a reaction bottle, and dichloromethane (250mL) was added. The reaction solution was cooled to about 0°C and methanesulfonyl chloride (13.74g, 0.12mol) was slowly added dropwise. After the addition was completed, the temperature naturally rose to 23°C to 27°C, and the reaction was stirred for 3 hours and 15 minutes. After the reaction was completed, post-treatment was carried out, and a saturated ammonium chloride solution (50mL) was added to the reaction solution to quench the reaction. Dichloromethane (2×50mL) was added to extract, and the organic phases were combined and washed with 50ml of saturated brine, dried over anhydrous sodium sulfate, and the filtrate was concentrated under reduced pressure to evaporate the solvent. The concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 10:1 to obtain the compound shown in formula 3, with an amount of 19.45g and a total yield of 88.7%.
[0077] Example 14 Synthesis of the compound represented by formula 3
[0078] At room temperature, the compound shown in formula 2 (14.12 g, 0.1 mol), K 2 CO 3 (20.73g, 0.15mol) was placed in a reaction bottle, and dichloromethane (250mL) was added. The reaction solution was cooled to about 0°C and methanesulfonyl chloride (13.74g, 0.12mol) was slowly added dropwise. After the addition was completed, the temperature naturally rose to 23°C~27°C, and the reaction was stirred for 3 hours and 15 minutes. After the reaction was completed, post-treatment was carried out, and a saturated ammonium chloride solution (50mL) was added to the reaction solution to quench the reaction. Dichloromethane (2×50mL) was added to extract, and the organic phases were combined and washed with 50ml of saturated brine, dried over anhydrous sodium sulfate, and the filtrate was concentrated under reduced pressure to evaporate the solvent. The concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 10:1 to obtain the compound shown in formula 3, with an amount of 19.56g and a total yield of 89.2%.
[0079] Comparative Example 2: Synthesis of the compound shown in Formula 3
[0080] The molar ratio of the compound represented by Formula 2, triethylamine and methanesulfonyl chloride was adjusted to 1:1.2:1.0.
[0081] At room temperature, the compound of formula 2 (14.12 g, 0.1 mol) and triethylamine (12.14 g, 0.12 mol) were placed in a reaction bottle, and dichloromethane (250 mL) was added. The reaction solution was cooled to about 0°C and methanesulfonyl chloride (11.45 g, 0.10 mol) was slowly added dropwise. After the addition was completed, the temperature naturally rose to 23°C to 27°C, and the reaction was stirred for 3 hours and 15 minutes. After the reaction was completed, post-treatment was performed, saturated ammonium chloride solution (50 mL) was added to the reaction solution to quench the reaction, and dichloromethane (2×50 mL) was added to extract. After the organic phases were combined, 50 ml of saturated brine was added to wash, and the mixture was dried over anhydrous sodium sulfate. The filtrate was concentrated under reduced pressure to evaporate the solvent, and the concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 10:1 to obtain the compound of formula 3, with an amount of 18.15 g and a total yield of 82.8%.
[0082] Comparative Example 3: Synthesis of the compound shown in Formula 3
[0083] The molar ratio of the compound represented by Formula 2, triethylamine and methanesulfonyl chloride was adjusted to 1:1.8:1.5, and the stirring reaction time was adjusted to 3 hours and 30 minutes.
[0084] At room temperature, the compound of formula 2 (14.12 g, 0.1 mol) and triethylamine (18.22 g, 0.18 mol) were placed in a reaction bottle, and dichloromethane (250 mL) was added. The reaction solution was cooled to about 0°C and methanesulfonyl chloride (17.18 g, 0.15 mol) was slowly added dropwise. After the addition was completed, the temperature naturally rose to 23°C to 27°C, and the reaction was stirred for 3 hours and 30 minutes. After the reaction was completed, post-treatment was performed, saturated ammonium chloride solution (50 mL) was added to the reaction solution to quench the reaction, and dichloromethane (2×50 mL) was added to extract. After the organic phases were combined, 50 ml of saturated brine was added for washing, and the mixture was dried over anhydrous sodium sulfate. The filtrate was concentrated under reduced pressure to evaporate the solvent, and the concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 10:1 to obtain the compound of formula 3, with an amount of 18.79 g and a total yield of 85.7%.
[0085] Example 15 Preparation of the compound represented by formula I, Futebatinib
[0086] At room temperature, the compound represented by formula 4 (29.53 g, 0.1 mol), the compound represented by formula 3 (28.50 g, 0.13 mol) and K 2 CO 3(15.20 g, 0.11 mol) was placed in a reaction bottle, and DMF (250 mL) was added to dissolve it. The temperature was kept at 45°C to 50°C for 2 hours under stirring. TLC showed that the raw material was completely reacted. The reaction solution was cooled to room temperature and then post-treated. 150 mL of water was added for washing, and ethyl acetate (2×150 ml) was used for extraction. The organic phases were combined and washed with 200 mL of saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 3:1 to obtain the compound represented by formula I, fulvibatinib, with an yield of 19.46 g, a total yield of 46.5%, and a purity of 99.4%.
[0087] LC-MS (APCI): m / z = 419.2 (M+1) + .
[0088] Example 16 Preparation of the compound represented by formula I, Futebatinib
[0089] At room temperature, the compound represented by formula 4 (29.53 g, 0.1 mol), the compound represented by formula 3 (35.08 g, 0.16 mol) and K 2 CO 3 (19.35 g, 0.14 mol) was placed in a reaction bottle, and DMF (250 mL) was added to dissolve it. The temperature was kept at 55°C to 60°C for 3 hours under stirring. TLC showed that the raw material was completely reacted. The reaction solution was cooled to room temperature and then post-treated. 150 mL of water was added for washing, and ethyl acetate (2×150 ml) was used for extraction. The organic phases were combined and washed with 200 mL of saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 8:1 to obtain the compound represented by formula I, fulvibatinib, with an yield of 20.17 g, a total yield of 48.2%, and a purity of 99.5%.
[0090] Example 17 Preparation of the compound represented by formula I, Futebatinib
[0091] At room temperature, the compound represented by formula 4 (29.53 g, 0.1 mol), the compound represented by formula 3 (32.89 g, 0.15 mol) and K 2 CO 3(16.58 g, 0.12 mol) was placed in a reaction bottle, and DMF (250 mL) was added to dissolve it. The temperature was kept at 50°C to 55°C with stirring for 2.5 hours. TLC showed that the raw material was completely reacted. The reaction solution was cooled to room temperature and then post-treated. 150 mL of water was added for washing, and ethyl acetate (2×150 ml) was used for extraction. The organic phases were combined and washed with 200 mL of saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 5:1 to obtain the compound represented by formula I, fulvibatinib, with an yield of 20.55 g, a total yield of 49.1%, and a purity of 99.7%.
[0092] Example 18 Preparation of the compound represented by formula I, Futebatinib
[0093] At room temperature, the compound represented by formula 4 (29.53 g, 0.1 mol), the compound represented by formula 3 (32.89 g, 0.15 mol) and Na 2 CO 3 (12.72 g, 0.12 mol) was placed in a reaction bottle, and DMF (250 mL) was added to dissolve it. The temperature was kept at 50°C to 55°C with stirring for 2.5 hours. TLC showed that the raw material was completely reacted. The reaction solution was cooled to room temperature and then post-treated. 150 mL of water was added for washing, and ethyl acetate (2×150 ml) was used for extraction. The organic phases were combined and washed with 200 mL of saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 5:1 to obtain the compound represented by formula I, fulvibatinib, with an yield of 19.67 g, a total yield of 47.0%, and a purity of 99.7%.
[0094] In the description of this specification, the description with reference to the terms "one embodiment", "some embodiments", "example", "specific example", or "some examples" etc. means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic representations of the above terms do not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described may be combined in any one or more embodiments or examples in a suitable manner. In addition, those skilled in the art may combine and combine the different embodiments or examples described in this specification and the features of the different embodiments or examples, without contradiction.
[0095] Although the embodiments of the present invention have been shown and described above, it is to be understood that the above embodiments are exemplary and are not to be construed as limitations of the present invention. A person skilled in the art may change, modify, replace and vary the above embodiments within the scope of the present invention.
Claims
1. A method for preparing futibatinib, It is characterized in that include: (1) contacting the compound represented by Formula 1 with an organic base A and acryloyl chloride to obtain the compound represented by Formula 2; (2) contacting the compound represented by Formula 2 with a basic substance B and methanesulfonyl chloride to obtain the compound represented by Formula 3; (3) contacting the compound represented by Formula 4, the compound represented by Formula 3, and an organic base C to obtain the compound represented by Formula I, fultebatinib, Wherein, the organic base A is at least one selected from triethylamine, isopropylamine, ethylenediamine, and DIPEA; The alkaline substance B is selected from triethylamine, isopropylamine, ethylenediamine, DIPEA, K 2 CO 3 、Na 2 CO 3 at least one of; The inorganic base C is at least one selected from sodium carbonate or potassium carbonate.
2. The method according to claim 1, It is characterized in that In step (1), the following steps are included: at room temperature, adding the compound represented by formula 1 and organic base A into a reaction bottle, adding dry dichloromethane, stirring evenly, cooling the reaction solution to -15°C to -5°C, and slowly adding acryloyl chloride dropwise. After the addition is complete, the temperature is maintained at -15°C to -5°C and stirred for 2 hours and 45 minutes to 3.5 hours. TLC shows that the raw materials are completely reacted, adding saturated ammonium chloride solution to the reaction solution to quench the reaction, adding dichloromethane to extract, combining the organic phases, adding saturated brine to wash, drying over anhydrous sodium sulfate, and concentrating the filtrate under reduced pressure to evaporate the solvent to obtain the compound represented by formula 2.
3. The method according to claim 2, It is characterized in that In step (1), the molar ratio of the compound represented by formula 1 to the organic base A and acryloyl chloride is 1:(1.2-1.5):(1.0-1.2), and preferably the molar ratio of the compound represented by formula 1 to the organic base A and acryloyl chloride is 1:1.3:1.
05.
4. The method according to claim 2, It is characterized in that In step (1), the organic base A is at least one selected from triethylamine, isopropylamine, ethylenediamine, and DIPEA, and preferably the organic base A is selected from triethylamine; Optionally, in step (1), after the dropwise addition is completed, the reaction is preferably stirred and maintained at -12°C to -8°C for 3 hours.
5. The method according to claim 1, It is characterized in that In step (2), the following steps are included: at room temperature, placing the compound shown in formula 2 and alkaline substance B in a reaction bottle, adding dichloromethane, cooling the reaction solution to about 0°C and then slowly adding methanesulfonyl chloride, and naturally raising the temperature to 20°C to 30°C after the addition is completed, stirring and reacting for 3 hours to 3.5 hours, and after the reaction is completed, performing post-treatment, adding saturated ammonium chloride solution to the reaction solution to quench the reaction, adding dichloromethane to extract, combining the organic phases, washing with saturated brine, drying over anhydrous sodium sulfate, concentrating the filtrate under reduced pressure to evaporate the solvent, and purifying the concentrate by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent to obtain the compound shown in formula 3.
6. The method according to claim 5, It is characterized in that In step (2), the molar ratio of the compound represented by formula 2 to the alkaline substance B and methanesulfonyl chloride is 1:(1.4-1.6):(1.1-1.3), and preferably the molar ratio of the compound represented by formula 2 to the alkaline substance B and methanesulfonyl chloride is 1:1.5:1.
2.
7. The method according to claim 5, It is characterized in that In step (2), the alkaline substance B is selected from triethylamine, isopropylamine, ethylenediamine, DIPEA, K 2 CO 3 、Na 2 CO 3 At least one of the alkaline substances B is preferably selected from triethylamine; Optionally, in step (2), the volume ratio of petroleum ether to ethyl acetate in the petroleum ether / ethyl acetate mixed solvent is (8-12):1, preferably the volume ratio of petroleum ether / ethyl acetate mixed solvent is 10:1; Optionally, in step (2), after the dropwise addition is completed, the temperature is preferably naturally raised to 23° C. to 27° C., and the reaction is stirred for 3 hours and 15 minutes.
8. The method according to claim 1, It is characterized in that In step (3), the following steps are included: placing the compound represented by formula 4, the compound represented by formula 3 and the inorganic base C in a reaction bottle at room temperature, adding DMF to dissolve, maintaining the temperature at 45°C to 60°C for 2 to 3 hours, TLC showing that the raw materials are completely reacted, cooling the reaction solution to room temperature, performing post-treatment, adding water for washing, extracting with ethyl acetate, combining the organic phases, adding saturated brine for washing, drying with anhydrous sodium sulfate, concentrating under reduced pressure, and purifying the concentrate by silica gel column chromatography with a petroleum ether / ethyl acetate mixed solvent to obtain the compound represented by formula I, fulvestrant.
9. The method according to claim 8, It is characterized in that In step (3), the molar ratio of the compound represented by formula 4, the compound represented by formula 3, and the organic base C is 1:(1.3-1.6):(1.1-1.4), preferably the molar ratio of the compound represented by formula 4, the compound represented by formula 3, and the organic base C is 1:1.5:1.2; Optionally, in step (3), the inorganic base C is at least one selected from sodium carbonate or potassium carbonate, preferably the inorganic base C is selected from potassium carbonate; Optionally, in step (3), the volume ratio of petroleum ether to ethyl acetate in the petroleum ether / ethyl acetate mixed solvent is (3-8):1, preferably the volume ratio of petroleum ether to ethyl acetate is 5:1; Optionally, in step (3), the reaction is preferably stirred at 50°C to 55°C for 2.5 hours.
10. The method according to claim 1, It is characterized in that In step (1), the following steps are included: at room temperature, the compound represented by formula 1 (8.71 g, 0.1 mol) and triethylamine (13.16 g, 0.13 mol) are added to a reaction bottle, dry dichloromethane (120 mL) is added, and the mixture is stirred evenly. The reaction solution is cooled to -12°C to -8°C and acryloyl chloride (9.50 g, 0.105 mol) is slowly added dropwise. After the addition is completed, the mixture is stirred at -12°C to -8°C for 3 hours. TLC shows that the raw materials have reacted completely. A saturated ammonium chloride solution (25 mL) is added to the reaction solution to quench the reaction. Dichloromethane (2×25 mL) is added to extract the mixture. After the organic phases are combined, 25 mL of saturated brine is added for washing, the mixture is dried over anhydrous sodium sulfate, and the filtrate is concentrated under reduced pressure to evaporate the solvent to obtain the compound represented by formula 2. The yield is 11.70 g and the yield is 82.9%. In step (2), the following steps are included: at room temperature, the compound of formula 2 (14.12 g, 0.1 mol) and triethylamine (15.18 g, 0.15 mol) are placed in a reaction bottle, dichloromethane (250 mL) is added, the reaction solution is cooled to about 0°C, and methanesulfonyl chloride (13.74 g, 0.12 mol) is slowly added dropwise, and the temperature is naturally raised to 23°C to 27°C after the addition is completed, and the reaction is stirred for 3 hours and 15 minutes. After the reaction is completed, post-treatment is performed, saturated ammonium chloride solution (50 mL) is added to the reaction solution to quench the reaction, dichloromethane (2×50 mL) is added to extract, the organic phases are combined, 50 ml of saturated brine is added, and the organic phases are washed, dried over anhydrous sodium sulfate, and the filtrate is concentrated under reduced pressure to evaporate the solvent. The concentrate is purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 10:1 to obtain a compound of formula 3, with an amount of 20.28 g and a total yield of 92.5%; In step (3), the following steps are included: at room temperature, the compound represented by formula 4 (29.53 g, 0.1 mol), the compound represented by formula 3 (32.89 g, 0.15 mol) and K 2 CO 3 (16.58 g, 0.12 mol) was placed in a reaction bottle, and DMF (250 mL) was added to dissolve it. The temperature was kept at 50°C to 55°C with stirring for 2.5 hours. TLC showed that the raw material was completely reacted. The reaction solution was cooled to room temperature and then post-treated. 150 mL of water was added for washing, and ethyl acetate (2×150 ml) was used for extraction. The organic phases were combined and washed with 200 mL of saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 5:1 to obtain the compound represented by formula I, fulvibatinib, with an yield of 20.55 g, a total yield of 49.1%, and a purity of 99.7%.
Citation Information
Patent Citations
3,5-disubstituted alkynylbenzene compound and salt thereof
CN103958512A
Method for preparing N-propylene carbonyl piperidine derivative
CN104945404A
Thieno-[3,2-c] pyridine type compound as well as preparation method and application thereof
CN104945411A
Preparation and application of novel pyrazolo [3,4-d] pyrimidines JAK kinase inhibitor
CN108329321A
